Related Experiment Videos
Echocardiographic evaluation of left ventricular hypertrophy
Journal of Cardiovascular Pharmacology
|January 1, 1986
Summary
Echocardiography is a sensitive tool for detecting left ventricular hypertrophy (LVH) in hypertension patients, revealing it in nearly 50% compared to other methods. This aids in identifying patients who may benefit most from targeted hypertension treatment.
Area of Science:
- Cardiology
- Hypertension Research
- Diagnostic Imaging
Background:
- Mild to moderate hypertension requires effective diagnostic methods for target organ involvement.
- Traditional methods like ECG and chest X-ray have limited sensitivity for detecting left ventricular hypertrophy (LVH).
- Echocardiography offers a more sensitive approach to assessing cardiac changes in hypertensive individuals.
Purpose of the Study:
- To evaluate the utility of echocardiography in diagnosing left ventricular hypertrophy (LVH) in patients with mild hypertension.
- To compare the sensitivity of echocardiography with electrocardiogram (ECG) and chest X-ray for LVH detection.
- To explore the role of echocardiography in identifying LVH in young and labile hypertensive patients.
Main Methods:
- Large-scale observations of patients with mild to moderate hypertension.
- Comparison of echocardiography findings with ECG and chest X-ray results.
- Echocardiographic assessment in young hypertensive patients and those with labile hypertension.
Main Results:
- Echocardiography identified LVH in almost 50% of patients, significantly higher than ECG and chest X-ray (approx. 5%).
- Over 30% of young hypertensive patients exhibited increased left ventricular muscle wall thickness.
- LVH was documented in young patients with labile hypertension, even with normal blood pressure during the procedure.
Conclusions:
- Echocardiography is a highly sensitive diagnostic tool for detecting LVH in hypertensive patients.
- LVH in hypertension is influenced by factors beyond blood pressure, including sympathetic nervous system activity.
- Sympatholytic agents may improve left ventricular mass independently of blood pressure effects, suggesting targeted treatment strategies.